Overview

Safety Study of APD-791 With Aspirin and/or Clopidogrel

Status:
Terminated
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
Evaluating safety and PK parameter of APD-791 when co-administered with aspirin and clopidogrel.
Phase:
Phase 1
Details
Lead Sponsor:
IlDong Pharmaceutical Co Ltd
Collaborator:
Asan Medical Center
Treatments:
APD791
Aspirin
Clopidogrel